000 01396 a2200421 4500
005 20250516163158.0
264 0 _c20131227
008 201312s 0 0 eng d
022 _a1095-6859
024 7 _a10.1016/j.ygyno.2013.07.105
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChen, Yu-Li
245 0 0 _aInterferon-gamma in ascites could be a predictive biomarker of outcome in ovarian carcinoma.
_h[electronic resource]
260 _bGynecologic oncology
_cOct 2013
300 _a63-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAscites
_xetiology
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aCarcinoma
_xcomplications
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterferon-gamma
_xmetabolism
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Grading
650 0 4 _aOvarian Neoplasms
_xcomplications
650 0 4 _aProportional Hazards Models
700 1 _aCheng, Wen-Fang
700 1 _aChang, Ming-Cheng
700 1 _aLin, Han-Wei
700 1 _aHuang, Ching-Ting
700 1 _aChien, Chung-Liang
700 1 _aChen, Chi-An
773 0 _tGynecologic oncology
_gvol. 131
_gno. 1
_gp. 63-8
856 4 0 _uhttps://doi.org/10.1016/j.ygyno.2013.07.105
_zAvailable from publisher's website
999 _c22977394
_d22977394